Publications
Sort:
Clinical Research Issue
Predictive value of C-reactive protein-albumin-lymphocyte index for adverse cardiovascular events in elderly patients with chronic heart failure
Chinese Journal of Multiple Organ Diseases in the Elderly 2026, 25(6): 417-422
Published: 28 June 2026
Abstract PDF (495.7 KB) Collect
Downloads:0
Objective

To explore the predictive value of C-reactive protein-albumin-lymphocyte (CALLY) index for occurence of major adverse cardiovascular events (MACE) in elderly patients with chronic heart failure, to evaluate its efficacy as a predictive indicator, and to analyze its independent predictive effect on the occurrence of MACE in a multifactorial model.

Methods

A total of 126 elderly patients with chronic heart failure admitted to Qinghai Red Cross Hospital from June 2021 to June 2023 were selected as the research subjects. All patients met the diagnostic criteria and had New York Heart Association (NYHA) Functional Classification grade ItoⅢ cardiac function. NYHA gradeⅣ, those with other severe cardiovascular diseases, autoimmune diseases and incomplete data were excluded. All the included subjects were tested for laboratory indicators, including C-reactive protein (CRP), albumin (ALB), and lymphocytes (LYM) after admission, and the CALLY index was calculated. The patients were divided into the MACE group (n=48) and the non-MACE group (n=78) based on whether MACE occurred during the one-year follow-up. Statistical analysis was performed using SPSS 25.0 and MedCalc software. The predictive value of the CALLY index for the occurrence of MACE in elderly patients with chronic heart failure was evaluated by the receiver operating characteristic (ROC) curve, and multivariate logistic regression analysis was used to explore the risk factors for the occurrence of MACE in elderly patients with chronic heart failure.

Results

NYHA grade Ⅲ, serum creatinine (SCr), CRP, N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left ventricular end-diastolic diameter (LVEDD) in MACE group were higher than those in non-MACE group, and ALB, LYM, CALLY index and left ventricular ejection fraction (LVEF) were lower than those in non-MACE group (P<0.05). The results of the ROC curve analysis showed that area under the curve (95%CI) of CRP, ALB, LYM and CALLY index for predicting the occurrence of MACE in elderly patients with chronic heart failure were 0.704 (0.654-0.754), 0.734 (0.684-0.784), 0.711 (0.661-0.761) and 0.820 (0.770-0.870), respectively. The results of the DeLong method showed that the predictive efficacy of the CALLY index was significantly higher than that of CRP, ALB and LYM (Z=3.215, 2.604, 3.578; P<0.05). Multivariate analysis showed that NYHA grade Ⅲ (OR=1.850, 95%CI 1.199-2.853), NT-proBNP>3124.18 pg/ml (OR=2.423, 95%CI 1.389-4.228), LVEF≤44.65% (OR=3.047, 95%CI 1.712-5.421), LVEDD>56.28 mm (OR=3.900, 95%CI 2.019-7.535) and CALLY index ≤0.56 (OR=4.371, 95%CI 2.129-8.974) were the risk factors for MACE in elderly patients with chronic heart failure (P<0.05).

Conclusion

The CALLY index of elderly patients with chronic heart failure who suffering MACE is significantly decreased and is closely related to the occurrence of MACE, which may serve as an effective indicator for evaluating the occurrence of MACE in these patients.

Total 1